The oral fibroblasts we describe in this manuscript, that were activated into CAFs through oral cancer cell-derived EVs, most likely constitute the CAF-S1 subtype, positive for both CD29 and FAP, while lacking expression of CAV1 (Table 1). Here, CAV1 is linked to lip and oral cavity carcinoma.